Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis

NCT04060147 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
11
Enrollment
INDUSTRY
Sponsor class

Stopped The study enrollment was terminated early by the sponsor due to recruitment challenges.

Conditions

Interventions

Sponsor

Gilead Sciences